Company: ICUI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000883984-25-000007
Chunk: 275

Company: ICU MEDICAL INC/DE
Filing Date: 2025-02-27
Form: 10-K
Item: Item 1
Chunk 275
---
4)$11,064 $5,800 $(5,394)$— $11,470 Warranty and return reserve - accounts receivable$7,505 $(1,441)$806 $— $6,870 Warranty and return reserve - inventory/accrued(5)$57,796 $2,571 $(18,146)$— $42,221 Deferred tax asset valuation allowance(6)$8,452 $78,592 $3,906 $— $90,950 

______________________________________________

(1) Includes an acquired balance of $3.8 million related to the Smiths Medical acquisition.

(2) Includes an acquired balance of $55.2 million in short-term and long-term accrued warranty reserve related to the Smiths Medical acquisition.

(3Additional charges to expense were primarily related to additional field corrective actions identified and initiated during the period related to the Smiths Medical business FDA warning letter  (See Note: 16 Commitments and Contingencies in our accompanying consolidated financial statements).

(4) The charged to other accounts includes a $2.0 million reclassification to assets held for sale related to the IV Solutions business (See Note 4: Assets held For Sale in our accompanying consolidated financial statements).

(5) Primarily includes payments for expenses related to our field corrective actions.

(6) Primarily relates to valuation allowance against certain U.S. federal and state deferred tax assets (See Note 14:  Income Taxes in our accompanying consolidated financial statements).

121

ITEM 16. FORM 10-K SUMMARY

    None

SIGNATURE

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 ICU MEDICAL, INC.    By:/s/ Vivek Jain  Vivek Jain  Chairman of the Board and Chief Executive Officer    Dated:February 27, 2025

SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Registrant and in the capacities and on the dates indicated.

Signature Title Date     /s/ Vivek Jain Chairman of the Board and February 27, 2025Vivek Jain